Barbieri, E., Deflorian, G., Pezzimenti, F., Valli, D., Saia, M., Meani, N., Gruszka, A.M., Alcalay, M. (2016) Nucleophosmin leukemogenic mutant activates Wnt signaling during zebrafish development. Oncotarget. 7(34):55302-55312
|
Deveau, A.P., Forrester, A.M., Coombs, A.J., Wagner, G.S., Grabher, C., Chute, I.C., Léger, D., Mingay, M., Alexe, G., Rajan, V., Liwski, R., Hirst, M., Steigmaier, K., Lewis, S.M., Look, A.T., Berman, J.N. (2015) Epigenetic therapy restores normal hematopoiesis in a zebrafish model of NUP98-HOXA9-induced myeloid disease. Leukemia. 29(10):2086-97
|
Fang, X., Xu, S., Zhang, Y., Xu, J., Huang, Z., Liu, W., Wang, S., Yen, K., Zhang, W. (2021) Asxl1 C-terminal mutation perturbs neutrophil differentiation in zebrafish. Leukemia. 35(8):2299-2310
|
Gjini, E., Jing, C.B., Nguyen, A.T., Reyon, D., Gans, E., Kesarsing, M., Peterson, J., Pozdnyakova, O., Rodig, S.J., Mansour, M.R., Joung, K., Look, A.T. (2019) Disruption of asxl1 results in myeloproliferative neoplasms in zebrafish. Disease models & mechanisms. 12(5):
|
He, B.L., Shi, X., Man, C.H., Ma, A.C., Ekker, S.C., Chow, H.C., So, C.W., Choi, W.W., Zhang, W., Zhang, Y., and Leung, A.Y. (2014) Functions of FMS-like tyrosine kinase 3 (flt3) in zebrafish hematopoiesis and its relevance to human acute myeloid leukemia. Blood. 123(16):2518-29
|
He, B.L., Yang, N., Man, C.H., Ng, N.K., Cher, C.Y., Leung, H.C., Kan, L.L., Cheng, B.Y., Lam, S.S., Wang, M.L., Zhang, C.X., Kwok, H., Cheng, G., Sharma, R., Ma, A.C., So, C.E., Kwong, Y.L., Leung, A.Y. (2020) Follistatin is a novel therapeutic target and biomarker in FLT3/ITD acute myeloid leukemia. EMBO Molecular Medicine. 12(4):e10895
|
Hou, H.A., Lu, J.W., Lin, T.Y., Tsai, C.H., Chou, W.C., Lin, C.C., Kuo, Y.Y., Liu, C.Y., Tseng, M.H., Chiang, Y.C., Peng, Y.L., Tang, J.L., Gong, Z., Lin, L.I., Tien, H.F. (2017) Clinico-biological significance of suppressor of cytokine signaling 1 expression in acute myeloid leukemia. Blood cancer journal. 7:e588
|
Kang, J.W., Kim, Y., Lee, Y., Myung, K., Kim, Y.H., Oh, C.K. (2020) AML poor prognosis factor, TPD52, is associated with the maintenance of haematopoietic stem cells through regulation of cell proliferation. Journal of cellular biochemistry. 122(3-4):403-412
|
|
|
|
|
Lazzaroni, F., Del Giacco, L., Biasci, D., Turrini, M., Prosperi, L., Brusamolino, R., Cairoli, R., Beghini, A. (2016) Intronless WNT10B-short variant underlies new recurrent allele-specific rearrangement in acute myeloid leukaemia. Scientific Reports. 6:37201
|
Liu, W., Wu, M., Huang, Z., Lian, J., Chen, J., Wang, T., Leung, A.Y., Liao, Y., Zhang, Z., Liu, Q., Yen, K., Lin, S., Zon, L.I., Wen, Z., Zhang, Y., Zhang, W. (2017) c-myb hyperactivity leads to myeloid and lymphoid malignancies in zebrafish. Leukemia. 31(1):222-233
|
|
|
Lu, J.W., Hsieh, M.S., Hou, H.A., Chen, C.Y., Tien, H.F., Lin, L.I. (2017) Overexpression of SOX4 correlates with poor prognosis of acute myeloid leukemia and is leukemogenic in zebrafish. Blood cancer journal. 7:e593
|
Ma, S., Yang, L.L., Niu, T., Cheng, C., Zhong, L., Zheng, M.W., Xiong, Y., Li, L.L., Xiang, R., Chen, L.J., Zhou, Q., Wei, Y.Q., Yang, S.Y. (2015) SKLB-677, an FLT3 and Wnt/β-catenin signaling inhibitor, displays potent activity in models of FLT3-driven AML. Scientific Reports. 5:15646
|
Mazzola, M., Deflorian, G., Pezzotta, A., Ferrari, L., Fazio, G., Bresciani, E., Saitta, C., Ferrari, L., Fumagalli, M., Parma, M., Marasca, F., Bodega, B., Riva, P., Cotelli, F., Biondi, A., Marozzi, A., Cazzaniga, G., Pistocchi, A. (2019) NIPBL: a new player in myeloid cells differentiation. Haematologica. 104(7):1332-1341
|
Mazzola, M., Pezzotta, A., Fazio, G., Rigamonti, A., Bresciani, E., Gaudenzi, G., Pelleri, M.C., Saitta, C., Ferrari, L., Parma, M., Fumagalli, M., Biondi, A., Cazzaniga, G., Marozzi, A., Pistocchi, A. (2020) Dysregulation of NIPBL leads to impaired RUNX1 expression and haematopoietic defects. Journal of Cellular and Molecular Medicine. 24(11):6272-6282
|
|
|
Oo, Z.M., Illendula, A., Grembecka, J., Schmidt, C., Zhou, Y., Esain, V., Kwan, W., Frost, I., North, T.E., Rajewski, R.A., Speck, N.A., Bushweller, J.H. (2017) A tool compound targeting the core binding factor Runt domain to disrupt binding to CBFβ in leukemic cells. Leukemia & lymphoma. 59(9):2188-2200
|
Piragyte, I., Clapes, T., Polyzou, A., Klein Geltink, R.I., Lefkopoulos, S., Yin, N., Cauchy, P., Curtis, J.D., Klaeylé, L., Langa, X., Beckmann, C.C.A., Wlodarski, M.W., Müller, P., Van Essen, D., Rambold, A., Kapp, F.G., Mione, M., Buescher, J.M., Pearce, E.L., Polyzos, A., Trompouki, E. (2018) A metabolic interplay coordinated by HLX regulates myeloid differentiation and AML through partly overlapping pathways. Nature communications. 9:3090
|
|
|
Selvaraju, K., Lotfi, K., Gubat, J., Miquel, M., Nilsson, A., Hill, J., Jensen, L.D., Linder, S., D'Arcy, P. (2021) Sensitivity of Acute Myelocytic Leukemia Cells to the Dienone Compound VLX1570 Is Associated with Inhibition of the Ubiquitin-Proteasome System. Biomolecules. 11(9):
|
Shen, L., Zhu, J., Chen, F., Lin, W., Cai, J., Zhong, J., Zhong, H. (2015) RUNX1-Evi-1 fusion gene inhibited differentiation and apoptosis in myelopoiesis: an in vivo study. BMC cancer. 15:970
|
Smith, K.M., Fagan, P.C., Pomari, E., Germano, G., Frasson, C., Walsh, C., Silverman, I., Bonvini, P., Li, G. (2018) Antitumor Activity of Entrectinib, a Pan-TRK, ROS1, and ALK Inhibitor, in ETV6-NTRK3-Positive Acute Myeloid Leukemia. Molecular cancer therapeutics. 17:455-463
|
Spreafico, M., Gruszka, A.M., Valli, D., Mazzola, M., Deflorian, G., Quintè, A., Totaro, M.G., Battaglia, C., Alcalay, M., Marozzi, A., Pistocchi, A. (2020) HDAC8: A Promising Therapeutic Target for Acute Myeloid Leukemia. Frontiers in cell and developmental biology. 8:844
|
Sun, R., Sun, L., Xie, X., Li, X., Wu, P., Wang, L., Zhu, P. (2022) Single-cell analysis of transcription factor regulatory networks reveals molecular basis for subtype-specific dysregulation in acute myeloid leukemia. Blood science (Baltimore, Md.). 4:65-75
|
Tan, J., Zhao, L., Wang, G., Li, T., Li, D., Xu, Q., Chen, X., Shang, Z., Wang, J., Zhou, J. (2018) Human MLL-AF9 Overexpression Induces Aberrant Hematopoietic Expansion in Zebrafish. BioMed Research International. 2018:6705842
|
Tregnago, C., Manara, E., Zampini, M., Bisio, V., Borga, C., Bresolin, S., Aveic, S., Germano, G., Basso, G., Pigazzi, M. (2016) CREB engages C/EBPδ to initiate leukemogenesis. Leukemia. 30(9):1887-96
|
Vicente, C., Arriazu, E., Martínez-Balsalobre, E., Peris, I., Marcotegui, N., García-Ramírez, P., Pippa, R., Rabal, O., Oyarzábal, J., Guruceaga, E., Prósper, F., Mateos, M.C., Cayuela, M.L., Odero, M.D. (2019) A novel FTY720 analogue targets SET-PP2A interaction and inhibits growth of acute myeloid leukemia cells without inducing cardiac toxicity. Cancer letters. 468:1-13
|
Wang, Q.F., Li, Y.J., Dong, J.F., Li, B., Kaberlein, J.J., Zhang, L., Arimura, F.E., Luo, R.T., Ni, J., He, F., Wu, J., Mattison, R., Zhou, J., Wang, C.Z., Prabhakar, S., Nobrega, M.A., and Thirman, M.J. (2014) Regulation of MEIS1 by distal enhancer elements in acute leukemia. Leukemia. 28(1):138-46
|
Warkentin, A.A., Lopez, M.S., Lasater, E.A., Lin, K., He, B., Leung, A.Y., Smith, C.C., Shah, N.P., Shokat, K.M. (2014) Overcoming myelosuppression due to synthetic lethal toxicity for FLT3-targeted acute myeloid leukemia therapy. eLIFE. 3
|
|
|
Yu, X., Munoz-Sagredo, L., Streule, K., Muschong, P., Bayer, E., Walter, R.J., Gutjahr, J.C., Greil, R., Concha, M.L., Müller-Tidow, C., Hartmann, T.N., Orian-Rousseau, V. (2021) CD44 loss of function sensitizes AML cells to the BCL-2 inhibitor venetoclax by decreasing CXCL12-driven survival cues. Blood. 138(12):1067-1080
|
Zhou, B., Li, H., Xing, C., Ye, H., Feng, J., Wu, J., Lu, Z., Fang, J., Gao, S. (2017) Honokiol induces proteasomal degradation of AML1-ETO oncoprotein via increasing ubiquitin conjugase UbcH8 expression in leukemia. Biochemical pharmacology. 128:12-25
|
